O
26
16
CF
47
5
BAC
38
3
KHC
11
2
PFE
37
4
FMC
23
7
MDT
59
4
CCI
30
2
KIM
58
2
DIS
70
2
LRCX
56
4
CRM
65
6
HUM
25
4
WMB
58
3
AIZ
61
5
ILMN
31
4
DHI
36
3
ZTS
38
4
CAT
47
3
CVS
27
2
O
26
16
CF
47
5
BAC
38
3
KHC
11
2
PFE
37
4
FMC
23
7
MDT
59
4
CCI
30
2
KIM
58
2
DIS
70
2
LRCX
56
4
CRM
65
6
HUM
25
4
WMB
58
3
AIZ
61
5
ILMN
31
4
DHI
36
3
ZTS
38
4
CAT
47
3
CVS
27
2
Financhill
Back

Royalty Pharma PLC 10K Form

Sell
32

RPRX
Royalty Pharma PLC

Last Price:
$24.97
Seasonality Move:
1.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09 10Q RPRX/Royalty Pharma PLC Quarterly
2023-11-08 10Q RPRX/Royalty Pharma PLC Quarterly
2023-08-08 10Q RPRX/Royalty Pharma PLC Quarterly
2023-05-09 10Q RPRX/Royalty Pharma PLC Quarterly
2022-11-08 10Q RPRX/Royalty Pharma PLC Quarterly
2022-08-04 10Q RPRX/Royalty Pharma PLC Quarterly

Receive RPRX News And Ratings

See the #1 stock for the next 7 days that we like better than RPRX

RPRX Financial Statistics

Sales & Book Value

Annual Sales: $2.4B
Cash Flow: $703.6M
Price / Cash Flow: 5.31
Annual Sales: $15.40
Price / Book: 1.61

Profitability

EPS (TTM): 2.55000
Net Income (TTM): $1.1B
Gross Margin: $0
Return on Equity: 11.56%
Return on Assets: 6.81%

Royalty Pharma PLC Earnings Forecast

Key Royalty Pharma PLC Financial Ratios

  • The Gross Profit Margin over the past 11 years for RPRX is 0.00%.
  • The Selling, General & Administrative Expenses for RPRX have been equal to 10.61% of Gross Profit Margin.
  • The Research & Development expenses have been 2.21% of Revenue.
  • The Interest Expense is 16.49% of Operating Income.
  • The Net Earning history of RPRX is 48.20% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 10 years.

Royalty Pharma PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RPRX
CUSIP: G7709Q
Website: royaltypharma.com

Debt

Debt-to-Equity Ratio: 1.11
Current Ratio: 1.54
Quick Ratio: 1.53

Price-to-Earnings

Trailing P/E Ratio: 9.86
Forward P/E Ratio: 5.95

RPRX Technical Analysis vs Fundamental Analysis

Sell
32
Royalty Pharma PLC (RPRX) is a Sell

Is Royalty Pharma PLC a Buy or a Sell?